Search

Your search keyword '"Masuda, Noriyuki"' showing total 35 results

Search Constraints

Start Over You searched for: Author "Masuda, Noriyuki" Remove constraint Author: "Masuda, Noriyuki" Publisher elsevier b.v. Remove constraint Publisher: elsevier b.v.
35 results on '"Masuda, Noriyuki"'

Search Results

12. Phase 2 Study of Nimotuzumab in Combination With Concurrent Chemoradiotherapy in Patients With Locally Advanced Non-Small-Cell Lung Cancer.

15. Nab-paclitaxel plus carboplatin as an effective and safe chemotherapy regimen for pulmonary carcinosarcoma with interstitial lung disease: A case report.

17. Endobronchial involvement of mantle cell lymphoma: A case report.

18. Characterization of hyperpolarization-activated current (I h) in dorsal root ganglion neurons innervating rat urinary bladder

19. P2.02-027 A Randomized Phase II Trial of S-1 plus Cisplatin or Docetaxel plus Cisplatin with Concurrent Thoracic Radiotherapy for Stage III NSCLC: TORG1018: Topic: Multimodality Treatment.

21. Effect of the third dose of BNT162b2 COVID-19 mRNA vaccine on anti-SARS-CoV-2 antibody levels in healthcare workers.

24. Activation of Akt involves resistance to NF-κB inhibition and abrogation of both triggers synergistic apoptosis in lung adenocarcinoma cells.

25. The clinicopathological significance of Lgr5 expression in lung adenocarcinoma.

26. Prognostic impact of nestin expression in resected large cell neuroendocrine carcinoma of the lung

27. Phase I Results of Vinorelbine With Concurrent Radiotherapy in Elderly Patients With Unresectable, Locally Advanced Non-Small-Cell Lung Cancer: West Japan Thoracic Oncology Group (WJTOG3005-DI)

28. The balance between the expressions of hASH1 and HES1 differs between large cell neuroendocrine carcinoma and small cell carcinoma of the lung

29. Phase I/II trial of gemcitabine plus oral TS-1 in elderly patients with advanced non-small cell lung cancer: Thoracic oncology research group study 0502

30. Expression of RACK1 is a novel biomarker in pulmonary adenocarcinomas

31. Successful oral desensitization against skin rash induced by alectinib in a patient with anaplastic lymphoma kinase-positive lung adenocarcinoma: A case report.

32. Synthesis and pharmacological evaluation of piperidinoalkanoyl-1,2,3,4-tetrahydroisoquinoline derivatives as novel specific bradycardic agents

33. Synthesis and pharmacological evaluation of N-acyl-1,2,3,4-tetrahydroisoquinoline derivatives as novel specific bradycardic agents

34. (±)-2-(3-Piperidyl)-1,2,3,4-tetrahydroisoquinolines as a new class of specific bradycardic agents

35. P2-099How should we exploit TAS-102?

Catalog

Books, media, physical & digital resources